Colgate-Palmolive (NYSE:CL) Rating Lowered to “Hold” at StockNews.com

Colgate-Palmolive (NYSE:CL) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Monday.

CL has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. UBS Group upped their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. Finally, Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research note on Monday, October 28th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $105.11.

Colgate-Palmolive Stock Up 0.6 %

Shares of Colgate-Palmolive stock opened at $93.48 on Monday. The stock’s 50-day moving average is $95.48 and its 200 day moving average is $98.70. Colgate-Palmolive has a one year low of $76.96 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $76.37 billion, a price-to-earnings ratio of 26.79, a PEG ratio of 3.31 and a beta of 0.43.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently made changes to their positions in the stock. DGS Capital Management LLC boosted its stake in Colgate-Palmolive by 35.9% during the third quarter. DGS Capital Management LLC now owns 8,625 shares of the company’s stock valued at $895,000 after buying an additional 2,280 shares during the period. Garde Capital Inc. boosted its stake in Colgate-Palmolive by 19.5% during the third quarter. Garde Capital Inc. now owns 1,553 shares of the company’s stock valued at $161,000 after buying an additional 253 shares during the period. Peapack Gladstone Financial Corp boosted its stake in Colgate-Palmolive by 2.4% during the third quarter. Peapack Gladstone Financial Corp now owns 50,653 shares of the company’s stock valued at $5,258,000 after buying an additional 1,203 shares during the period. Tidal Investments LLC boosted its stake in Colgate-Palmolive by 351.0% during the third quarter. Tidal Investments LLC now owns 284,568 shares of the company’s stock valued at $29,541,000 after buying an additional 221,469 shares during the period. Finally, Wilmington Savings Fund Society FSB boosted its stake in Colgate-Palmolive by 125.0% during the third quarter. Wilmington Savings Fund Society FSB now owns 51,333 shares of the company’s stock valued at $5,329,000 after buying an additional 28,518 shares during the period. 80.41% of the stock is owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.